Tag Archives: Stun

Horizon Discovery licenses CHOSOURCE to Sanyou Biopharmaceuticals Co.

[ad_1] 2 December 2020 Horizon Discovery Group plc, a global leader in applying gene editing and gene modulation to cell line engineering, today announced that it has granted two commercial licenses for its cGMP-compliant CHOSOURCE ™ platform to Sanyou Biopharmaceuticals Co., Ltd., a leading biotechnology company focused on the research, …

Read More »